Ground News

Don't Just Read the News, Understand It.

pharmatimes.com image

News from pharmatimes.com

Your destination for news from pharmatimes.com. See how pharmatimes.com’s media bias impacts the breaking news stories of today.

We’ve discovered 64 headlines written by pharmatimes.com during the past 3 months.

pharmatimes.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is pharmatimes.com credible or reliable? Our Factuality score answers both of those questions. When it comes to pharmatimes.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about pharmatimes.com

Where is pharmatimes.com located?pharmatimes.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmatimes.com News

UCB reports success in phase 3 study of fenfluramine for CDD

UCB reports success in phase 3 study of fenfluramine for CDD

Positive trial results offer hope for those with ultra-rare epileptic disorder Read Article

Cidara and hVIVO report positive results in flu prevention study

Cidara and hVIVO report positive results in flu prevention study

New data show strong efficacy of CD388 in phase 2b trial Read Article

NHS ConfedExpo 2025: A Platform for Change in UK Health and Care

NHS · Manchester

NHS ConfedExpo 2025: A Platform for Change in UK Health and Care

Introduction This year’s NHS ConfedExpo took place on 11–12 June at Manchester Central, bringing together around 9000 attendees. Among them were over 5,000 health and care leaders, with roughly one in three attendees representing C‑suite roles. The programme featured more than 500 speakers and over 150 exhibitors, establishing it as the UK’s largest health and […]See the Story

Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health

The programme was unveiled at this year’s NHS ConfedExpo in ManchesterManchester, England · Manchester Read Article

2025 PharmaTimes Clinical Researcher of the Year

Enter this year's famous competition Read Article

eXmoor and Signadori Bio enter cell therapy partnership

Signadori is advancing a platform designed to overcome the challenges of treating solid cancers Read Article

Teva and Fosun Pharma partner on early-stage oncology drug

The candidate is being evaluated as both a monotherapy and in combination pembrolizumab Read Article

EDX medical partners with spire healthcare to advance disease diagnostics

Collaboration aims to improve rapid detection and personalised treatmentsUnited Kingdom · United Kingdom Read Article

Bispecific Antibodies in the Treatment of Multiple Myeloma

100% Center coverage: 1 sources

The treatment paradigm in myeloma is constantly changing. Upfront use of monoclonal antibodies like daratumumab along with proteasome inhibitors (PI)s, and immune modulators (IMiD)s have significantly improved survival and outcomes, but also cause unique challenges at the time of relapse. Engaging immune T cells for tumour cell kill with chimeric antigenic T-cell (CAR T-cell) therapy and bispecific antibodies have become important therapeutic op…See the Story

Pregnancy: No Reason Not to Treat Migraine

100% Right coverage: 1 sources

Sumatriptan and onabotulinumtoxinA are safe options during pregnancy.European Parliament See the Story

Levicept presents new LEVI-04 data at EULAR

Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Read Article

Breaking News Topics Related to pharmatimes.com